Showing results for : 225ac psma 617

225Ac-PSMA-617 – A New Beginning in the Treatment of Chemotherapy-Naive Prostate Cancer Patients

For advanced prostate cancer patients or metastatic castration-resistant prostate cancer (mCRPC) patients, conventional treatment modalities, such as surgery, chemotherapy etc. might not prove to be highly effective in terms of controlling the spread of the cancer. This is where Nuclear Medicine and Molecular Imaging are playing an important part in the management of cancer and that too in a personalized manner.

Read more